Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Doody, RS"" wg kryterium: Autor


Tytuł:
Plasma sphingomyelins are associated with cognitive progression in Alzheimer's disease.
Autorzy:
Mielke MM
Haughey NJ
Bandaru VV
Weinberg DD
Darby E
Zaidi N
Pavlik V
Doody RS
Lyketsos CG
Mielke, Michelle M
Haughey, Norman J
Bandaru, Veera Venkata Ratnam
Weinberg, Danielle D
Darby, Eveleen
Zaidi, Noman
Pavlik, Valory
Doody, Rachelle S
Lyketsos, Constantine G
Pokaż więcej
Źródło:
Journal of Alzheimer's Disease; 2011, Vol. 23 Issue 1, p259-269, 11p
Czasopismo naukowe
Tytuł:
Long-Term Treatment with Lithium Alleviates Memory Deficits and Reduces Amyloid-[beta] Production in an Aged Alzheimer's Disease Transgenic Mouse Model.
Autorzy:
Zhang X
Heng X
Li T
Li L
Yang D
Du Y
Doody RS
Le W
Pokaż więcej
Źródło:
Journal of Alzheimer's Disease; 2011, Vol. 23 Issue 1, p739-749, 11p
Czasopismo naukowe
Tytuł:
Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer's disease.
Autorzy:
Bateman RJ; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA. .; Dominantly Inherited Alzheimer's Network (DIAN) and The Knight Family DIAN Trials Unit (DIAN-TU), St. Louis, MO, USA. .
Cummings J; Department of Brain Health, Chambers-Grundy Center for Transformative Neuroscience, School of Integrated Health Sciences, University of Nevada Las Vegas, Las Vegas, NV, USA.
Schobel S; Product Development, F. Hoffmann-La Roche, Basel, Switzerland.
Salloway S; Departments of Psychiatry, Human Behavior, and Neurology, Warren Alpert Medical School of Brown University, Providence, RI, USA.; Department of Neurology, Butler Hospital, Providence, RI, USA.; Brown University Center for Alzheimer's Disease Research, Robert J. and Nancy D. Carney Institute for Brain Science, Providence, RI, USA.
Vellas B; Department of Geriatric Internal Medicine, UMR 1295 Mixed Unit INSERM - Université Toulouse III Paul Sabatier, Toulouse University Hospital, Toulouse, France.
Boada M; Ace Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
Black SE; Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.; LC Campbell Cognitive Neurology Research Unit, Dr Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Fontoura P; Product Development, F. Hoffmann-La Roche, Basel, Switzerland.
Klein G; Roche Pharma Research and Early Development, F. Hoffmann-La Roche, Basel, Switzerland.
Assunção SS; US Medical Affairs, Genentech Inc., a member of the Roche Group, South San Francisco, CA, USA.
Smith J; Product Development, Roche Products Ltd., Welwyn Garden City, UK.
Doody RS; Product Development, F. Hoffmann-La Roche, Basel, Switzerland.; Product Development, Genentech Inc., a member of the Roche Group, South San Francisco, CA, USA.
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2022 Nov 29; Vol. 14 (1), pp. 178. Date of Electronic Publication: 2022 Nov 29.
Typ publikacji:
Journal Article; Review; Research Support, N.I.H., Extramural
MeSH Terms:
Alzheimer Disease*/drug therapy
Amyloidosis*
United States ; Humans ; Amyloidogenic Proteins ; Plaque, Amyloid ; Asymptomatic Diseases
Czasopismo naukowe
Tytuł:
Erratum to: PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury.
Autorzy:
Hammond FM; Physical Medicine and Rehabilitation, Indiana University School of Medicine, Rehabilitation Hospital of Indiana, 4141 Shore Drive, Indianapolis, IN, 46254, USA. .
Alexander DN; University of California, Los Angeles, CA, USA.
Cutler AJ; Florida Clinical Research Center, LLC, Bradenton, FL, USA.
D'Amico S; Cornerstone Medical Group, Franklin, TN, USA.
Doody RS; Baylor College of Medicine, Houston, TX, USA.
Sauve W; TMS NeuroHealth Centers, Richmond, VA, USA.
Zorowitz RD; MedStar National Rehabilitation Network, Washington, DC, USA.
Davis CS; CSD Biostatistics, Inc., Tucson, AZ, USA.
Shin P; Avanir Pharmaceuticals, Inc., Aliso Viejo, CA, USA.
Ledon F; Avanir Pharmaceuticals, Inc., Aliso Viejo, CA, USA.
Yonan C; Avanir Pharmaceuticals, Inc., Aliso Viejo, CA, USA.
Formella AE; Avanir Pharmaceuticals, Inc., Aliso Viejo, CA, USA.
Siffert J; Avanir Pharmaceuticals, Inc., Aliso Viejo, CA, USA.
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2016 Sep 02; Vol. 16 (1), pp. 160. Date of Electronic Publication: 2016 Sep 02.
Typ publikacji:
Published Erratum
Tytuł:
PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury.
Autorzy:
Hammond FM; Physical Medicine and Rehabilitation, Indiana University School of Medicine, Rehabilitation Hospital of Indiana, 4141 Shore Drive, Indianapolis, IN, 46254, USA. .
Alexander DN; University of California, Los Angeles, CA, USA.
Cutler AJ; Florida Clinical Research Center, LLC, Bradenton, FL, USA.
D'Amico S; Cornerstone Medical Group, Franklin, TN, USA.
Doody RS; Baylor College of Medicine, Houston, TX, USA.
Sauve W; TMS NeuroHealth Centers, Richmond, VA, USA.
Zorowitz RD; MedStar National Rehabilitation Network, Washington, DC, USA.
Davis CS; CSD Biostatistics, Inc., Tucson, AZ, USA.
Shin P; Avanir Pharmaceuticals, Inc., Aliso Viejo, CA, USA.
Ledon F; Avanir Pharmaceuticals, Inc., Aliso Viejo, CA, USA.
Yonan C; Avanir Pharmaceuticals, Inc., Aliso Viejo, CA, USA.
Formella AE; Avanir Pharmaceuticals, Inc., Aliso Viejo, CA, USA.
Siffert J; Avanir Pharmaceuticals, Inc., Aliso Viejo, CA, USA.
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2016 Jun 09; Vol. 16, pp. 89. Date of Electronic Publication: 2016 Jun 09.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Dextromethorphan/*therapeutic use
Excitatory Amino Acid Antagonists/*therapeutic use
Pseudobulbar Palsy/*drug therapy
Quinidine/*therapeutic use
Aged ; Brain Injuries, Traumatic/complications ; Dementia/complications ; Dextromethorphan/administration & dosage ; Drug Administration Schedule ; Drug Combinations ; Excitatory Amino Acid Antagonists/administration & dosage ; Female ; Humans ; Male ; Middle Aged ; Pseudobulbar Palsy/complications ; Quinidine/administration & dosage ; Severity of Illness Index ; Stroke/complications ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Prevalence and correlates of cognitive asymmetry in a large sample of Alzheimer's disease patients.
Autorzy:
Alverson WA; a Department of Psychology , University of Houston , Houston , TX , USA.
Massman PJ; b Department of Neurology , Baylor College of Medicine , Houston , TX , USA.
Doody RS; b Department of Neurology , Baylor College of Medicine , Houston , TX , USA.
Pokaż więcej
Źródło:
Journal of clinical and experimental neuropsychology [J Clin Exp Neuropsychol] 2016; Vol. 38 (5), pp. 516-26. Date of Electronic Publication: 2016 Jan 12.
Typ publikacji:
Journal Article
MeSH Terms:
Alzheimer Disease/*complications
Alzheimer Disease/*epidemiology
Cognition Disorders/*complications
Cognition Disorders/*epidemiology
Aged ; Aged, 80 and over ; Apolipoprotein E4/genetics ; Female ; Humans ; Male ; Neuropsychological Tests ; Prevalence ; Psychiatric Status Rating Scales ; Statistics as Topic
Czasopismo naukowe
Tytuł:
Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer's disease clinical trials.
Autorzy:
Grill JD; Institute for Memory Impairments and Neurological Disorders Department of Psychiatry and Human Behavior 3206 Biological Sciences, University of California, Irvine, CA 92697-4545 USA.
Raman R; Alzheimer's Disease Cooperative Study, University of California, San Diego, San Diego, CA USA.
Ernstrom K; Alzheimer's Disease Cooperative Study, University of California, San Diego, San Diego, CA USA.
Aisen P; Alzheimer's Disease Cooperative Study, University of California, San Diego, San Diego, CA USA.
Dowsett SA; Eli Lilly & Company, Indianapolis, IN USA.
Chen YF; Eli Lilly & Company, Indianapolis, IN USA.
Liu-Seifert H; Eli Lilly & Company, Indianapolis, IN USA.
Hake AM; Eli Lilly & Company, Indianapolis, IN USA.
Miller DS; Bracket, Wayne, PA USA.
Doody RS; Department of Neurology, Baylor College of Medicine, Houston, TX USA.
Henley DB; Eli Lilly & Company, Indianapolis, IN USA.
Cummings JL; Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV USA.
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2015 Jun 25; Vol. 7 (1), pp. 39. Date of Electronic Publication: 2015 Jun 25 (Print Publication: 2015).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Alzheimer's disease progression by geographical region in a clinical trial setting.
Autorzy:
Henley DB; Eli Lilly and Company, Indianapolis, IN 46285 USA ; Indiana University School of Medicine, Indianapolis, IN 46202 USA.
Dowsett SA; Eli Lilly and Company, Indianapolis, IN 46285 USA.
Chen YF; Eli Lilly and Company, Indianapolis, IN 46285 USA.
Liu-Seifert H; Eli Lilly and Company, Indianapolis, IN 46285 USA.
Grill JD; University of California, Irvine, Institute for Memory Impairments and Neurological Disorders, 3206 Biological Sciences III, Irvine, CA 92697-4545 USA.
Doody RS; University of California, Irvine, Institute for Memory Impairments and Neurological Disorders, 3206 Biological Sciences III, Irvine, CA 92697-4545 USA.
Aisen P; Baylor College of Medicine, Department of Neurology, Houston, TX 77030 USA.
Raman R; University of California San Diego School of Medicine, 9500 Gilman Drive, La Jolla, CA 92093-0717 USA.
Miller DS; Dementia and Geriatric Psychiatry, Bracket, 575 E. Swedesford Rd, Ste 200, Wayne, PA 19087 USA.
Hake AM; Eli Lilly and Company, Indianapolis, IN 46285 USA ; Indiana University School of Medicine, Indianapolis, IN 46202 USA.
Cummings J; Cleveland Clinic Lou Ruvo Center for Brain Health, 888 W Bonneville, Las Vegas, NV 89106 USA.
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2015 Jun 25; Vol. 7 (1), pp. 43. Date of Electronic Publication: 2015 Jun 25 (Print Publication: 2015).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Peripheral and central effects of γ-secretase inhibition by semagacestat in Alzheimer's disease.
Autorzy:
Doody RS; Alzheimer's Disease and Memory Disorders center, Department of Neurology, Baylor College of Medicine, 1977 Butler Blvd, Suite E5.101 Houston, TX USA.
Raman R; Division of Biostatistics and Bioinformatics, Department of Family and Preventive Medicine, Department of Neurosciences, University of California San Diego, 9500 Gilman Drive, M/C 0949, La Jolla, CA 92093 USA ; Department of Neurosciences, University of California San Diego, 9500 Gilman Drive, M/C 0949, La Jolla, CA, 92093 USA.
Sperling RA; Department of Neurology, Harvard Medical School, 220 Longwood Avenue, Goldenson Building, Room 420, Boston, MA 02115 USA.
Seimers E; Eli Lilly & Company, Lilly Corporate Center, Indianapolis, IN 46285 USA.
Sethuraman G; Eli Lilly & Company, Lilly Corporate Center, Indianapolis, IN 46285 USA.
Mohs R; Eli Lilly & Company, Lilly Corporate Center, Indianapolis, IN 46285 USA.
Farlow M; Department of Neurology, Indiana University, Indiana Alzheimer Disease Center, 355 W. 16th Street, Suite 4700, Indianapolis, IN 46202 USA.
Iwatsubo T; Graduate School of Medicine, University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8654 Japan.
Vellas B; Gerontopole UMR INSERM 1027, CHU, University of Toulouse, Toulouse, France.
Sun X; Biostatistics Research Center, Department of Family and Preventive Medicine, University of California San Diego, 9500 Gilman Drive, M/C 0949, La Jolla, CA 92093 USA.
Ernstrom K; Biostatistics Research Center, Department of Family and Preventive Medicine, University of California San Diego, 9500 Gilman Drive, M/C 0949, La Jolla, CA 92093 USA.
Thomas RG; Department of Neurosciences, University of California San Diego, 9500 Gilman Drive, M/C 0949, La Jolla, CA, 92093 USA ; Alzheimer's Disease Cooperative Study, Department of Family and Preventive Medicine, Department of Neurosciences, University of California San Diego, 9500 Gilman Drive M/C 0949, La Jolla, CA 92093 USA.
Aisen PS; Department of Neurosciences, University of California San Diego, 9500 Gilman Drive, M/C 0949, La Jolla, CA, 92093 USA.
Pokaż więcej
Corporate Authors:
Alzheimer’s Disease Cooperative Study
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2015 Jun 10; Vol. 7 (1), pp. 36. Date of Electronic Publication: 2015 Jun 10 (Print Publication: 2015).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Joint coverage probability in a simulation study on Continuous-Time Markov Chain parameter estimation.
Autorzy:
Benoit JS; Department of Vision Sciences/Texas Institute of Measurement, Evaluation, &Statistics (TIMES), University of Houston, Houston, TX, USA.; Department of Biostatistics, University of Texas School of Public Health, Houston, TX, USA.
Chan W; Department of Biostatistics, University of Texas School of Public Health, Houston, TX, USA.
Doody RS; Department of Neurology, Baylor College of Medicine, Houston, TX, USA.
Pokaż więcej
Źródło:
Journal of applied statistics [J Appl Stat] 2015; Vol. 42 (12), pp. 2531-2538. Date of Electronic Publication: 2015 Aug 20.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
The Dementia and Disability Project in Thai Elderly: rational, design, methodology and early results.
Autorzy:
Senanarong V; Faculty of Medicine, Siriraj Hospital, Mahidol University, 2 Prannok Rd., Bangkok, Thailand.
Harnphadungkit K
Poungvarin N
Vannasaeng S
Chongwisal S
Chakorn T
Jamjumrus P
Raksthaput A
Chaichanettee S
Aoonkaew N
Udompunthurak S
Doody RS
Cummings JL
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2013 Jan 10; Vol. 13, pp. 3. Date of Electronic Publication: 2013 Jan 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Disabled Persons*
Cognitive Dysfunction/*epidemiology
Cognitive Dysfunction/*etiology
Dementia/*complications
Dementia/*epidemiology
Aged ; Aged, 80 and over ; Dementia/diagnosis ; Female ; Humans ; Male ; Mental Disorders/epidemiology ; Mental Disorders/etiology ; Middle Aged ; Neuropsychological Tests ; Regression Analysis ; Residence Characteristics ; Thailand/epidemiology ; Triglycerides/blood
Czasopismo naukowe
Tytuł:
Factors that influence survival in a probable Alzheimer disease cohort.
Autorzy:
Rountree SD; Alzheimer's Disease and Memory Disorders Center, Department of Neurology, Baylor College of Medicine, 1977 Butler Boulevard, Suite E5,101, Houston, TX 77030, USA. .
Chan W
Pavlik VN
Darby EJ
Doody RS
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2012 May 15; Vol. 4 (3), pp. 16. Date of Electronic Publication: 2012 May 15.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Should persons with autosomal dominant AD be included in clinical trials? Authors' response.
Autorzy:
Szigeti K; Department of Neurology, Baylor College of Medicine, One Butler Boulevard, Suite E5,101, Houston, TX 77030, USA. .
Doody RS
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2011 May 23; Vol. 3 (3), pp. 19. Date of Electronic Publication: 2011 May 23.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Should EOAD patients be included in clinical trials?
Autorzy:
Szigeti K; Department of Neurology and Alzheimer's Disease and Memory Disorders Center, Baylor College of Medicine, 7200B Cambridge Street, Suite E5,101, Houston, TX 77030, USA. .
Doody RS
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2011 Feb 08; Vol. 3 (1), pp. 4. Date of Electronic Publication: 2011 Feb 08.
Typ publikacji:
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies